Füsun GÖKTAŞ, Nesrin CESUR, Dilek ŞATANA, Meltem UZUN

Synthesis of novel imidazo[1,2-a]pyridines and evaluation of their antifungal activities

New 2-(imidazo[1,2-a]pyridin-2-ylcarbonyl)-N-substituted hydrazinecarbothioamides (4a--j), N'-(3-substituted-4-oxo-1,3-thiazolidin-2-ylidene)imidazo[1,2-a]pyridine-2-carbohydrazides (5a--f), and N-(nonsubstituted/4-substituted phenyl)-5-(imidazo[1,2-a]pyridine-2-yl)-1,3,4-oxadiazole-2-amines (6a--d) were synthesized from imidazo[1,2-a]pyridine-2-carbohydrazide (3) and evaluated for antifungal activity against Microsporum gypseum NCPF 580, M. canis, Trichophyton tonsurans NCPF 245, T. rubrum, Candida albicans ATCC 10231, and C. parapsilosis ATCC 22019 using amphotericin B as the standard. The chemical structures of the compounds were confirmed by elemental analysis, IR, 1H NMR, 13C NMR, HMBC (13C, 1H), and mass spectra. Most of the tested compounds showed moderate antifungal activity. Hydrazinecarbothioamide derivatives 4h and 4f exhibited the highest activity against M. canis (MIC: 2 m g mL-1 and 4 m g mL-1, respectively).

Anahtar Kelimeler:

Imidazo[1, 2-a]pyridine, hydrazinecarbothioamide, 4-oxo-1, 3-thiazolidine, 1, 3, 4-oxadiazole, antifungal activity

Synthesis of novel imidazo[1,2-a]pyridines and evaluation of their antifungal activities

Keywords:

Imidazo[1, 2-a]pyridine, hydrazinecarbothioamide, 4-oxo-1, 3-thiazolidine, 1, 3, 4-oxadiazole, antifungal activity,

PDF

___

Enguehard-Gueiffier, C.; Gueiffier, A. Mini-Rev. Med. Chem. 2007, 7, 888–899.
Insuasty, B.; Guti´errez, A.; Qiroga, J.; Abonia, R.; Nogueras, M.; Cobo, J.; Svetaz, L.; Raimondi, M.; Zacchino, S. Arch. Pharm. Chem. Life Sci. 2010, 343, 48–53.
Emami, S.; Foroumadi, A. Arch. Pharm. Chem. Life Sci. 2009, 342, 541–545.
Cesur, N.; Cesur, Z.; Ergenc, N.; Uzun, M.; Kiraz, M.; Kasımoglu, O.; Kaya, D. Arch. Pharm. (Weinheim, Ger.) 1994, 327, 271–272.
Cesur, N.; Birteksoz, S.; Otuk, G. Acta Pharm. Turc. 2002, 44, 23–41.
Cesur, Z.; Cesur, N.; Birteksoz, S.; Otuk, G. Acta Chim. Slov. 2010, 57, 355–362.
Lombardino, G. J. J. Org. Chem. 1965, 30, 2403-2407.
Turan-Zitonui, G.; Blache, G.; Guven, K. Boll. Chim. Farm. 2001, 140, 397–400.
Cesur, N.; Cesur, Z.; G¨ursoy, A. Arch. Pharm. (Weinheim, Ger.) 1992, 325, 623– 624.
Capan, G.; Ulusoy, N.; Ergenc, N.; Kiraz, M. Monatsh. Chem. 1999, 130, 1399– 1407.
Terzioglu Klip, N.; Capan, G.; Gursoy, A.; Uzun, M.; Satana, D. J. Enzyme Inhib. Med. Chem. 2010, 25, 126–131.
G¨ursoy, A.; Karalı, N. Farmaco 1995, 50, 857–866.
Kasimogullari, B. O.; Cesur, Z. Molecules 2004, 9, 894–901.
Ur, F.; Cesur, N.; Birteksoz, S.; Otuk, G. Arzneim.-Forsch/Drug Res. 2004, 54, 125–129.
Ulusoy Guzeldemirci, N.; Ilhan, E.; Kucukbasmacı, O.; Satana, D. Arch. Pharm. Res. 2010, 33, 17–24.
Kucukguzel, S. G.; Oruc, E. E.; Rollas, S.; Sahin, F.; Ozbek, A. Eur. J. Med. Chem. 2002, 37, 197–206.
Kumar, S. Chem. Pap. 2012, 66, 216–220.
National Committee for Clinical Laboratory Standards. 2002 Reference Method for Broth Dilution Antifungal
Susceptibility Testing of Yeasts; Approved standard, 2nd ed. NCCLS document M27-A2. National Committee for Clinical Laboratory Standards, Wayne, PA, USA. 2002.
National Committee for Clinical Laboratory Standards. 2002 Reference Method for Broth Dilution Antifungal
Susceptibility Testing of Yeasts; Approved standard, 2nd ed. NCCLS document M38A. National Committee for Clinical Laboratory Standards, Wayne, PA, USA. 2002.
Fernandez-Torres, B.; Cabanes, F. J.; Carillo-Munoz, A.; Esteban, A.; Inza, I.; Abarca, L.; Guarro, J. J. Clin. Microbiol. 2002, 40, 3999–4003.
Rodriguez-Tudela, J. L.; Berenguer, J.; Martiiiez-Suarez, J. V.; Sanchez, R. Antimicrob. Agents Chemother. 1996, 40, 1998–2003.